STOCK TITAN
  1. Home
  2. News
  3. 2022-10-02

Stock Market News 2022-10-02

13 news published.

2022-10-01 2022-10-03
IMPACT
SENTIMENT
10/02/2022 11:02 PM
GTII : OTC
Global Tech Industries Group, Inc. Announces a Change from the Board Decision Regarding the Strike Price for the Outstanding Warrants
IMPACT
SENTIMENT
10/02/2022 08:00 PM
XPEV : NYSE
XPENG Receives Third Consecutive MSCI ESG Rating of AA Achieves Industry-leading DJSI Scores
IMPACT
SENTIMENT
10/02/2022 08:00 PM
CXM : NYSE
Sprinklr Expands Research and Development Center in Singapore
IMPACT
SENTIMENT
10/02/2022 08:00 PM
BILI : Nasdaq
Bilibili Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited
IMPACT
SENTIMENT
10/02/2022 07:51 PM
MESO : Nasdaq
Mesoblast Submits New Information to FDA IND File in Response to Items in the CRL to the Remestemcel-L BLA for SR-aGVHD
IMPACT
SENTIMENT
10/02/2022 07:36 PM
MYOV : NYSE
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
acquisition
IMPACT
SENTIMENT
10/02/2022 05:43 PM
RIO : NYSE
Rio Tinto calls for resignation of Energy Resources of Australia Chairman
management
IMPACT
SENTIMENT
10/02/2022 04:30 PM
FEAM : Nasdaq
5E Advanced Materials to Host Investor Webcast
conferences
IMPACT
SENTIMENT
10/02/2022 03:33 PM
DUK : NYSE
More than 900,000 customers restored as Duke Energy Florida outages stand at 77,000 on Sunday afternoon
IMPACT
SENTIMENT
10/02/2022 01:00 PM
LXRX : Nasdaq
New Analysis of SOLOIST-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events
IMPACT
SENTIMENT
10/02/2022 12:00 PM
TSLA : Nasdaq
Tesla Vehicle Production & Deliveries and Date for Financial Results & Webcast for Third Quarter 2022
earnings
IMPACT
SENTIMENT
10/02/2022 11:15 AM
HZNP : Nasdaq
New Data Reveal Molecular Drivers of Thyroid Eye Disease (TED) May Remain Activated In Patients with Low Clinical Activity Score (CAS)
IMPACT
SENTIMENT
10/02/2022 09:45 AM
CYTK : Nasdaq
Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting
clinical trial
2022-10-01 2022-10-03